HK1010495A1 - Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene - Google Patents

Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene

Info

Publication number
HK1010495A1
HK1010495A1 HK98111812A HK98111812A HK1010495A1 HK 1010495 A1 HK1010495 A1 HK 1010495A1 HK 98111812 A HK98111812 A HK 98111812A HK 98111812 A HK98111812 A HK 98111812A HK 1010495 A1 HK1010495 A1 HK 1010495A1
Authority
HK
Hong Kong
Prior art keywords
raloxifene
prophylaxis
administration
relating
breast cancer
Prior art date
Application number
HK98111812A
Other languages
English (en)
Inventor
Fredric Jay Cohen
Joan Ellen Glusman
Ronald Keith Knickerbocker
Nikolaus Thomas Nickelsen
Teri Janine Scott
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1010495(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1010495A1 publication Critical patent/HK1010495A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
HK98111812A 1996-10-30 1998-11-06 Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene HK1010495A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
HK1010495A1 true HK1010495A1 (en) 1999-06-25

Family

ID=27268608

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98111812A HK1010495A1 (en) 1996-10-30 1998-11-06 Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene

Country Status (44)

Country Link
US (2) US6303634B1 (no)
EP (3) EP0839533A1 (no)
JP (2) JPH10147529A (no)
CN (2) CN1182591A (no)
AP (1) AP971A (no)
AR (2) AR010538A1 (no)
AT (2) ATE338551T1 (no)
AU (3) AU5005197A (no)
BE (2) BE1011382A5 (no)
BG (1) BG63841B1 (no)
BR (1) BR9712703A (no)
CA (2) CA2219377A1 (no)
CH (2) CH691847A5 (no)
CZ (2) CZ300261B6 (no)
DE (2) DE69721692T2 (no)
DK (2) DK0839532T3 (no)
EA (2) EA002054B1 (no)
EE (1) EE03663B1 (no)
ES (4) ES2135342B1 (no)
FR (2) FR2755014B1 (no)
GB (3) GB2318734B (no)
GE (1) GEP20032910B (no)
GR (2) GR970100409A (no)
HK (1) HK1010495A1 (no)
HU (2) HUP9701777A3 (no)
IE (2) IE970772A1 (no)
IL (2) IL122026A0 (no)
IS (1) IS5035A (no)
IT (2) IT1298470B1 (no)
LU (2) LU90157B1 (no)
LV (1) LV12353B (no)
MY (1) MY121623A (no)
NL (2) NL1007387C2 (no)
NO (2) NO974973D0 (no)
NZ (1) NZ329042A (no)
PT (2) PT839532E (no)
RO (1) RO120813B1 (no)
SG (2) SG72765A1 (no)
SI (3) SI0839532T1 (no)
SK (1) SK287047B6 (no)
TR (1) TR199900951T2 (no)
UA (1) UA46762C2 (no)
WO (2) WO1998018449A1 (no)
YU (1) YU42397A (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) * 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
DE60202954T2 (de) 2001-05-22 2006-01-05 Eli Lilly And Co., Indianapolis Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel
ATE321754T1 (de) 2001-05-22 2006-04-15 Lilly Co Eli 2-substituierte 1,2,3,4-tetrahydrochinoline und derivate davon, zusammensetzungen und verfahren
US20040225200A1 (en) * 2003-05-09 2004-11-11 Edmundson Catherine M. System and method of analyzing the health of a population
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN102973573B (zh) * 2012-11-28 2015-04-08 玉林师范学院 一种人乳腺癌细胞抑制剂及制备方法
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
CN116650484A (zh) * 2023-05-11 2023-08-29 南通大学 一种乳腺癌相关蛋白的抑制剂及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
EP0652004B1 (en) * 1993-10-15 2002-07-10 Eli Lilly And Company Methods for treating resistant neoplasms
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
ZA951497B (en) * 1994-03-02 1996-08-23 Lilly Co Eli Orally administerable pharmaceutical formulations
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
CZ300341B6 (cs) * 1996-03-26 2009-04-22 Eli Lilly And Company Farmaceutická kompozice obsahující raloxifen

Also Published As

Publication number Publication date
SK287047B6 (sk) 2009-10-07
EA006083B1 (ru) 2005-08-25
HUP9701778A2 (hu) 1999-01-28
BG103369A (en) 2000-05-31
AU731388B2 (en) 2001-03-29
CA2219377A1 (en) 1998-04-30
IT1298470B1 (it) 2000-01-10
BE1011382A5 (fr) 1999-08-03
ES2135343A1 (es) 1999-10-16
US6303634B1 (en) 2001-10-16
US20020019418A1 (en) 2002-02-14
LV12353A (lv) 1999-10-20
IE970773A1 (en) 2000-02-09
EA002054B1 (ru) 2001-12-24
CH691847A5 (fr) 2001-11-15
CZ341297A3 (cs) 1998-05-13
LU90157B1 (fr) 1998-06-02
GB9722801D0 (en) 1997-12-24
DE69736644D1 (de) 2006-10-19
FR2755014A1 (fr) 1998-04-30
EP0839532A1 (en) 1998-05-06
CZ341197A3 (cs) 1998-05-13
MY121623A (en) 2006-02-28
PT1369115E (pt) 2006-12-29
CN1182590A (zh) 1998-05-27
ATE239475T1 (de) 2003-05-15
IS5035A (is) 1999-04-27
DE69721692T2 (de) 2004-03-25
GB9722796D0 (en) 1997-12-24
CZ300261B6 (cs) 2009-04-01
CA2219070C (en) 2007-12-18
FR2756490B1 (fr) 2003-06-20
SK55999A3 (en) 2000-06-12
HU9701777D0 (en) 1997-12-29
HU9701778D0 (en) 1997-12-29
ES2197312T3 (es) 2004-01-01
SI1369115T1 (sl) 2006-12-31
ES2135342B1 (es) 2000-05-16
TR199900951T2 (xx) 1999-07-21
AU5005697A (en) 1998-05-22
AR013864A1 (es) 2001-01-31
JPH10147529A (ja) 1998-06-02
EP0839532B1 (en) 2003-05-07
AP971A (en) 2001-05-30
GB2318734A (en) 1998-05-06
NZ329042A (en) 1999-08-30
EP1369115A1 (en) 2003-12-10
SI0839532T1 (en) 2003-10-31
HUP9701777A3 (en) 1999-07-28
ATE338551T1 (de) 2006-09-15
EA200100716A1 (ru) 2002-06-27
IL122025A0 (en) 1998-03-10
NO974973D0 (no) 1997-10-28
NL1007387C2 (nl) 1998-05-14
PT839532E (pt) 2003-09-30
WO1998018325A1 (en) 1998-05-07
GB2318734B (en) 1999-12-01
SG83672A1 (en) 2001-10-16
NO974972L (no) 1998-05-04
GEP20032910B (en) 2003-03-25
IL122026A0 (en) 1998-03-10
NL1007386C2 (nl) 1998-05-14
RO120813B1 (ro) 2006-08-30
DK0839532T3 (da) 2003-08-25
LU90158B1 (fr) 1998-06-02
MX9708340A (es) 1998-08-30
AU4364897A (en) 1998-05-07
AU4364797A (en) 1998-05-07
HUP9701777A2 (hu) 1999-06-28
SI20107A (sl) 2000-06-30
IE970772A1 (en) 2000-02-09
NO322468B1 (no) 2006-10-09
CN1182591A (zh) 1998-05-27
FR2755014B1 (fr) 1999-02-05
EP0839533A1 (en) 1998-05-06
IL122025A (en) 2003-01-12
DE69736644T2 (de) 2007-10-25
AP9901494A0 (en) 1999-03-31
HUP9701778A3 (en) 1999-06-28
ES2271476T3 (es) 2007-04-16
JPH10147530A (ja) 1998-06-02
ITMI972433A1 (it) 1999-04-29
WO1998018449A1 (en) 1998-05-07
ITMI972434A1 (it) 1999-04-29
GR1003189B (el) 1999-09-01
GB9911557D0 (en) 1999-07-21
EE03663B1 (et) 2002-04-15
MX9708341A (es) 1998-08-30
CH693820A5 (fr) 2004-02-27
EA199900431A1 (ru) 1999-10-28
SG72765A1 (en) 2000-05-23
AR010538A1 (es) 2000-06-28
DE69721692D1 (de) 2003-06-12
GB2318733A (en) 1998-05-06
ES2135342A1 (es) 1999-10-16
NO974972D0 (no) 1997-10-28
YU42397A (sh) 2000-10-30
GR970100408A (el) 1998-06-30
GR970100409A (el) 1998-06-30
EE9900162A (et) 1999-12-15
FR2756490A1 (fr) 1998-06-05
UA46762C2 (uk) 2002-06-17
CA2219070A1 (en) 1998-04-30
BE1011381A5 (fr) 1999-08-03
LV12353B (en) 2000-02-20
DK1369115T3 (da) 2007-01-02
EP1369115B1 (en) 2006-09-06
BG63841B1 (bg) 2003-03-31
AU5005197A (en) 1998-05-22
BR9712703A (pt) 1999-10-26

Similar Documents

Publication Publication Date Title
IL96148A0 (en) Tissue moisturizing composition
HK1010495A1 (en) Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene
GB9127140D0 (en) Improvements in or relating to the lining of passageways
EP0444451A3 (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
GB2273868B (en) Improvements relating to surgical tables
GB2243546B (en) Improvements in or relating to shower cubicles
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
GB2240265B (en) Improvements relating to tables
GB2301282B (en) Improvements relating to surgical tables
GB2246426B (en) Improvement in or relating to luminaires
GB8918523D0 (en) Improvements to bi-pivotal orthopaedic hinges
GB9219043D0 (en) Improvements in or relating to sanitary ware
GB9015278D0 (en) Preparation for application to skin
GB8908847D0 (en) Therapeutic compositions
GB9008780D0 (en) Therapeutic compositions
ZA979720B (en) Prophylaxis of breast cancer
GB8820341D0 (en) Improvements relating to cytotoxin
GB8820337D0 (en) Improvements relating to cytotoxin
GB8820340D0 (en) Improvements relating to cytotoxin
GB8820342D0 (en) Improvements relating to cytotoxin
HUT67367A (en) Topical composition for incresing the volume of the female breast
GB9017548D0 (en) Therapeutic preparation
GB9001467D0 (en) Improvements relating to lamp-holders
GB9005535D0 (en) Improvements relating to immunoradiotherapy
GB9008413D0 (en) Improvements relating to plant-pots

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20071029